SkylineDx to Present Cutting-Edge Research at Melanoma Congress
SkylineDx to Showcase Innovative Research at Oncology Congress
SkylineDx, a leader in molecular diagnostics for oncology, inflammatory, and infectious diseases, has announced its participation in a significant upcoming event. The company will present late-breaking data on its pioneering Merlin test during a prominent session and a poster presentation at the Society for Melanoma Research (SMR). This event is highly anticipated by experts and stakeholders in the field.
Details of the Oral Presentation
One of the highlights for SkylineDx at the congress will be an oral presentation during Plenary Session 10, focusing on late-breaking clinical abstracts. This presentation will detail the findings of the MERLIN_001 Trial, which examines the clinicopathological and gene expression profile tests to predict sentinel node status in T1-T3 cNO melanoma.
Presentation Schedule
The oral presentation is scheduled for Sunday, and will begin at 10:45 AM CDT. It will be led by Dr. Vernon K. Sondak, Department Chair of Cutaneous Oncology at Moffitt Cancer Center, who will share key insights derived from groundbreaking research in melanoma treatment.
Poster Presentation Insights
Additionally, SkylineDx will present a poster titled CP-GEP Identifies T1a Melanoma Patients at Risk of Sentinel Lymph Node Metastasis. This poster session will take place on Friday, running from 1:00 to 2:00 PM CDT, and will be presented by Dr. Alex Meves from the Mayo Clinic. This session promises to shed light on new ways to identify melanoma patients who are at risk for metastasis, enhancing the clinical approach to treatment.
Key Features of the CP-GEP Model
The CP-GEP, or the Merlin test, represents a significant advancement in predictive modeling for melanoma patients. This non-invasive model integrates clinicopathological information with gene expression profiles to identify patients who are at low risk of nodal metastasis. Consequently, these patients may avoid unnecessary surgical procedures, such as sentinel lymph node biopsies, reducing the physical burden of treatment.
About SkylineDx and Its Innovations
SkylineDx's commitment to innovation is emblematic of its role in transforming the landscape of cancer diagnostics. The company is not just focused on product development but also on bridging the gap between academic findings and practical diagnostic tools that can enhance clinical utility. Their collaborative efforts within the medical community support the development of high-performance diagnostic products, enabling healthcare professionals to provide individualized treatment plans to patients based on specific test outcomes.
Furthermore, the Merlin test has already been launched in various markets, including the United States and Europe. In the U.S., Tempus is responsible for commercializing the Tempus Merlin test. In addition, Quest Diagnostics has introduced its own version of the CP-GEP model under the name MelaNodal Predict™, showcasing the widespread adoption and recognition of this innovative diagnostic tool.
Conclusion: An Important Gathering for Melanoma Research
The upcoming Society for Melanoma Research congress is a crucial event where leading researchers and industry professionals will convene to discuss advancements in melanoma research and treatment options. SkylineDx is proud to contribute to this dialogue and share its findings from the Merlin test. The data presented could reshape how clinicians handle melanoma diagnostics and treatment strategies, ensuring better outcomes for patients.
Frequently Asked Questions
What is the Merlin test?
The Merlin test is a non-invasive prediction model designed to assess the risk of metastasis in melanoma patients by combining clinical data with gene expression profiles.
Who will present the findings at the congress?
Dr. Vernon K. Sondak will present the oral findings, while Dr. Alex Meves will deliver the poster presentation on the Merlin test.
When will the oral presentation take place?
The oral presentation is scheduled for Sunday at 10:45 AM CDT during the Plenary Session 10.
What is the significance of the CP-GEP model?
The CP-GEP model helps identify patients at low risk for sentinel lymph node metastasis, potentially allowing them to skip invasive biopsy procedures.
Where is SkylineDx based?
SkylineDx is headquartered in Rotterdam, the Netherlands, with an operational base and laboratory in San Diego, California.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Market Update: Technology Stocks Shine Amidst Oil Price Declines
- Vitol Fuels Growing Venezuelan Oil Trade to Indian Refineries
- US Natural Gas Production to Drop Amid Rising Demand in 2024
- Alignment Healthcare Boosted to $14 Target Amid Growth Surge
- Grid Dynamics Achieves 52-Week High Amid Growth Initiatives
- Franklin Wireless Secures Leadership with New Indemnification Agreements
- Fish Window Cleaning Rises on Franchise Times Top 400 List
- Mesabi Trust Surges to Yearly Max with Strong Stock Growth
- Eurozone Inflation Decline Continues, Yet ECB Calls for Caution
- Argentina's Inflation Rate Sees Positive Shift in September
Recent Articles
- T2 Biosystems and Prxcision Forge Partnership to Tackle Sepsis
- Arkansas Department of Labor Enhances Efficiency with Tyler Technologies
- Neonode Welcomes Peter Kruk to Its Board of Directors
- Lexaria Bioscience's Strategic Moves in the GLP-1 Market Growth
- LIBERTY Dental Plan Secures New Managed Care Contract
- Transforming Cybersecurity: NopalCyber Welcomes Vikram Chabra
- Knightscope Enhances Safety with Renewed FDNY Partnership
- Genius Group's CEO Expands Stake with 500,000 Shares Purchase
- Nortech Systems Expands Expertise with IPC-J-STD-001 Certification
- RBC Capital Markets Affirms Optimistic Outlook for Nasdaq
- Carlsmed Welcomes Kevin O’Boyle to Its Board of Directors
- Truist Affirms Buy Rating and Price Target for PENN Entertainment
- Growing Need for Postmortem Brain Tissue in Autism Research
- Unlocking Opportunities: Native USDC Launches on Sui Network
- Royal Gold Announces Q3 2024 Sales Performance and Results
- Tech Stock Spotlight: Three Companies Poised for Growth
- General Idea Appoints Tanner Graham as New CEO and Expands Team
- S&P 500 Faces Volatility: What Lies Ahead for Investors?
- The Container Store Implements New Stockholder Rights Plan
- Discovering Hidden Values in Blue-Chip Stock Investments
- Axinn's Transformative Rebranding: A New Era Begins
- Programs Plus Moves to Ascot Specialty for Habitational Program
- Tyto Athene Welcomes Rick Johnson as Chief Financial Officer
- Highland Real Estate Partners Secures Initial Funding for New Fund
- IGI Readies for Key Financial Results Announcement
- Tetra Tech Secures Major Water Management Deal Worth £800 Million
- Awangarda-Marketing Unveils Innovative Lead Generation Offers
- Stride Launches 100x: A Smart Solution to Tech Challenges
- Exploring the Telehealth Market: Trends and Growth Prospects
- Colbeck Capital Ready to Engage at Leading Sponsor Conference
- Global Crates Market Forecast: USD 8.5 Billion by 2034
- Exciting Developments Surrounding NVIDIA's Upcoming GPUs
- Mobi.AI Expands Leadership with Strategic Board Additions
- Future Insights: Smart Meter Market Set for Major Growth
- Yext Enhances AI Tools for Review Management Across Platforms
- Industrial Gases Market: Growth Potential Beyond $161 Billion
- Rottendorf Pharma Enhances Validation with ValGenesis VLMS
- Coop Liising AS Welcomes New Board Member Janek Rüütalu
- Yukon Metals Corp. Transitions to OTCQB for Enhanced Liquidity
- Socotra Appoints Greg Murphy to Lead Global Partnerships
- Transforming Workplace Culture: Insights from O.C. Tanner's Report
- MoneyHero Transforms Car Insurance with bolttech Partnership
- Middlefield Canadian Income PCC Reports Impressive Net Asset Value
- SpotHero Enhances Parking Experience with Google Integration
- Roger Hamilton Expands Stake in Genius Group Amid Growth
- Treasury Prime and ComplyCo Unite to Enhance Bank Compliance
- Vow ASA Unveils Strategic Rights Issue for Growth and Innovation
- Majesco Introduces Groundbreaking Innovations in Insurance Tech
- Natural Products Canada Highlights Bioinnovation Leaders in 2024
- N2OFF and Ethiopian Federal Agency Partner for Green Farming